Find Pranoprofen manufacturers, exporters & distributors on PharmaCompass

Pranoprofen

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 1 JDMF, 2 Listed Suppliers

3 API Suppliers
1 JDMF
2 Listed Suppliers

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 Europe

2 FDF Dossiers
2 Europe

GLOBAL SALES INFORMATION

2 Finished Drug Prices

globalSalesInformation
2 Finished Drug Prices

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

4INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 52549-17-4, Niflan, Pyranoprofen, 2-(5h-chromeno[2,3-b]pyridin-7-yl)propanoic acid, Elicapric, Y-8004

Molecular Formula

C₁₅H₁₃NO₃

Molecular Weight

255.27 g/mol

InChI Key

TVQZAMVBTVNYLA-UHFFFAOYSA-N

FDA UNII

2R7O1ET613

1 2D Structure

Pranoprofen

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid

2.1.2 InChI

InChI=1S/C15H13NO3/c1-9(15(17)18)10-4-5-13-12(7-10)8-11-3-2-6-16-14(11)19-13/h2-7,9H,8H2,1H3,(H,17,18)

2.1.3 InChI Key

TVQZAMVBTVNYLA-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C1=CC2=C(C=C1)OC3=C(C2)C=CC=N3)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

2R7O1ET613

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 2-(5h-(1)benzopyrano(2,3-b)pyridin-7-yl)propionic Acid

2. Alpha-methyl-5h-(1)benzopyrano(2,3-b)pyridine-7-acetic Acid

3. Niflan

4. Nifran

5. Oftalar

6. Pyranoprofen

7. Pyranoprofen, Methyl-14c-labeled

8. Zaltoprofen

2.3.2 Depositor-Supplied Synonyms

1. 52549-17-4

2. Niflan

3. Pyranoprofen

4. 2-(5h-chromeno[2,3-b]pyridin-7-yl)propanoic Acid

5. Elicapric

6. Y-8004

7. Nsc-759832

8. 2-{5h-chromeno[2,3-b]pyridin-7-yl}propanoic Acid

9. 2-(5h-(1)benzopyrano(2,3-b)pyridin-7-yl)propionic Acid

10. Chembl367463

11. 2r7o1et613

12. 2-(5h-[1]benzopyrano[2,3-b]pyridin-7-yl)propionic Acid

13. Ncgc00167980-01

14. Dsstox_cid_3497

15. Dsstox_rid_77055

16. Dsstox_gsid_23497

17. Pranoprofene

18. Pranoprofeno

19. Pranoprofenum

20. Pranoprofen [inn:jan]

21. Pranoprofene [inn-french]

22. Pranoprofenum [inn-latin]

23. Pranoprofeno [inn-spanish]

24. Cas-52549-17-4

25. Sr-05000001513

26. Brn 0889798

27. Pransus

28. Unii-2r7o1et613

29. Pranoprofen;

30. Elicapric (tn)

31. 2-(5h-(1)benzopyrano(2,3-b)pyridin-7yl)propionic Acid

32. Alpha-methyl-5h-(1)-benzopyrano(2,3-b)pyridine-7-acetic Acid

33. Alpha-methyl-5h-(1)benzopyrano(2,3-b)pyridine-7-acetic Acid

34. Pranoprofen [mi]

35. Pranoprofen [inn]

36. Pranoprofen [jan]

37. Pranoprofen (jp17/inn)

38. Pranoprofen [mart.]

39. Schembl26008

40. Pranoprofen [who-dd]

41. Dtxsid1023497

42. Chebi:32040

43. Pranoprofen, >=98% (hplc)

44. (2s)-2-(5h-chromeno[2,3-b]pyridin-7-yl)propanoic Acid

45. Hms2090j03

46. Hms3651g06

47. Hms3714i03

48. Hms3884o16

49. Pharmakon1600-01502324

50. 5h-(1)benzopyrano(2,3,-b)pyridine-7-acetic Acid, Alpha-methyl-

51. Bcp11947

52. Ex-a5741

53. Hy-b0336

54. Tox21_112601

55. 5h-[1]benzopyrano[2,3-b]pyridine-7-acetic Acid, .alpha.-methyl-

56. Ac-697

57. Bdbm50286819

58. Mfcd00866111

59. Nsc759832

60. S1960

61. Akos015918442

62. Tox21_112601_1

63. Ccg-213822

64. Db13514

65. Nsc 759832

66. Ncgc00167980-02

67. As-12631

68. Ft-0652901

69. P2778

70. Sw199147-2

71. D01578

72. F17350

73. Ab01275517-01

74. Ab01275517_02

75. Ab01275517_03

76. 2-(5h-chromeno[2,3-b]pyridin-7-yl)propanoicacid

77. 549p174

78. Q-201611

79. Q7238394

80. Sr-05000001513-1

81. Sr-05000001513-2

82. Brd-a64610707-001-01-0

83. I2-(10h-9-oxa-1-aza-anthracen-6-yl)-propionic Acid

84. 2-(5h-[1]benzopyrano-[2,3-b]pyridin-7-yl)propionic Acid

85. .alpha.-methyl-5h-(1)benzopyrano(2,3-b)pyridine-7-acetic Acid

2.4 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₁₃NO₃
Molecular Weight	255.27 g/mol
XLogP3	2.7
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	2
Exact Mass	255.08954328 g/mol
Monoisotopic Mass	255.08954328 g/mol
Topological Polar Surface Area	59.4 Å²
Heavy Atom Count	19
Formal Charge	0
Complexity	346
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Gout Suppressants

Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

4.2 ATC Code

S01BC09

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

S - Sensory organs

S01 - Ophthalmologicals

S01B - Antiinflammatory agents

S01BC - Antiinflammatory agents, non-steroids

S01BC09 - Pranoprofen

API SUPPLIERS